Forsyth Barr has upgraded its rating on listed healthcare company F&P Healthcare (FPH) from underperform to neutral after an in-depth look into its prospects for gaining market share in the huge global market for anaesthesia products.
In a research note, analysts Matt Montgomerie and Ben Crozier
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
